EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Adsorption of antigen to polymeric nanoparticles enhances cytotoxic T‐cell responses and anti‐tumor immunity by targeting conventional type 1 dendritic cells

Jorge Huete-Carrasco iD, Jingjing Zhu, Benoit J Van den Eynde, Christian Thomas Mayer, Tim Sparwasser, Ross W Ward iD, Ed C Lavelle

Immunology & Cell Biology · 2025

DOI: 10.1111/imcb.70049 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immunology & Cell Biology, 2025. Verfasst von Jorge Huete-Carrasco und 6 weiteren Autor:innen. Beteiligte Einrichtung: Adjuvant Research Group, Trinity Biomedical Sciences Institute, School of Biochemistry and Immunology, Trinity College Dublin, Dublin 2, Ireland. Hauptthemen laut MEDLINE: Dendritic Cells, Nanoparticles, T-Lymphocytes, Cytotoxic, Cancer Vaccines. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Irish Research Council/Research Ireland, Science Foundation Ireland through a Frontiers of the future award, Deutsche Forschungsgemeinschaft (DFG, German Research Foundation).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tumor rejection is primarily mediated by cytotoxic T cells, making them critical targets for therapeutic cancer vaccines. Vaccine adjuvants can modulate innate immunity, influencing adaptive immune responses. For particulate adjuvants, such as polymeric nanoparticles, physicochemical properties—including size, charge, composition and antigen location within the formulation—can shape these responses. Free‐soluble antigens typically fail to induce sufficient dendritic cell maturation and cross‐presentation needed for robust CD8 + T‐cell activation. However, this can be enhanced by delivering antigen with nanoparticles of appropriate size. While adjuvants like oil‐in‐water emulsions do not require antigen association for vaccine efficacy, the importance of antigen location in the adjuvanticity of polymeric nanoparticles is less clear. We demonstrate that colocalization of antigen and polymeric nanoparticles through antigen adsorption enhances proliferation and activation of antigen‐specific CD8 + T cells following intramuscular vaccination. While type 1 conventional dendritic cells (cDC1) can prime CD8 + T cells in other settings, their requirement with polymeric nanoparticles has not been fully addressed. We show that nanoparticle‐induced CD8 + T‐cell responses rely on cDC1s. The therapeutic efficacy of a polymeric nanoparticle vaccine was significantly enhanced when antigen was adsorbed on nanoparticles, leading to reduced tumor growth and prolonged survival in mice challenged with immunologically hot (MC38) and cold (B16F10) tumors expressing ovalbumin. Furthermore, vaccination with nanoparticle‐adsorbed antigen synergized with anti‐PD‐1 checkpoint blockade, enhancing protection, especially against B16F10‐ovalbumin tumors. This work highlights the role of antigen association with polymeric nanoparticles in eliciting CD8 + T‐cell responses for the development of effective therapeutic cancer vaccines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dendritic CellsNanoparticlesT-Lymphocytes, CytotoxicCancer VaccinesPolymersAntigens, NeoplasmAntigensAnimalsMiceMice, Inbred C57BLAdsorptionCD8-Positive T-LymphocytesFemaleLymphocyte Activation

Stichwörter der Autor:innen

Adjuvantscancer vaccinesconventional type 1 dendritic cellscytotoxic T cellsimmunotherapypolymeric nanoparticles

Substanzen

Cancer VaccinesPolymersAntigens, NeoplasmAntigens

Autor:innen und Institutionen

  • Adjuvant Research Group, Trinity Biomedical Sciences Institute, School of Biochemistry and Immunology, Trinity College Dublin, Dublin 2, Ireland.
  • Ludwig Institute for Cancer Research, Brussels, Belgium.
  • de Duve Institute, Université Catholique de Louvain, Brussels, B-1200, Belgium.
  • Walloon Excellence in Life Sciences and Biotechnology, Brussels, Belgium.
  • Experimental Immunology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
  • Institute of Medical Microbiology and Hygiene, University Medical Center of the Johannes University Gutenberg, Mainz, Germany.

ORCID-Profile: Jorge Huete-Carrasco, Ross W Ward

Förderung

  • Irish Research Council/Research Ireland
  • Science Foundation Ireland through a Frontiers of the future award
  • Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)

Zitieren

APA

Huete-Carrasco, J., Zhu, J., Van den Eynde, B. J., Mayer, C. T., Sparwasser, T., Ward, R. W., & Lavelle, E. C. (2025). Adsorption of antigen to polymeric nanoparticles enhances cytotoxic T‐cell responses and anti‐tumor immunity by targeting conventional type 1 dendritic cells. Immunology & Cell Biology. https://doi.org/10.1111/imcb.70049

Vancouver

Huete-Carrasco J, Zhu J, Van den Eynde BJ, Mayer CT, Sparwasser T, Ward RW, et al. Adsorption of antigen to polymeric nanoparticles enhances cytotoxic T‐cell responses and anti‐tumor immunity by targeting conventional type 1 dendritic cells. Immunology & Cell Biology. 2025. doi:10.1111/imcb.70049

BibTeX
@article{HueteCarrasco2025,
  author = {Huete-Carrasco, Jorge and Zhu, Jingjing and Van den Eynde, Benoit J and Mayer, Christian Thomas and Sparwasser, Tim and Ward, Ross W and Lavelle, Ed C},
  title = {Adsorption of antigen to polymeric nanoparticles enhances cytotoxic T‐cell responses and anti‐tumor immunity by targeting conventional type 1 dendritic cells},
  journal = {Immunology & Cell Biology},
  year = {2025},
  doi = {10.1111/imcb.70049}
}
Kostenlos starten →